Filing Details
- Accession Number:
- 0001140361-11-036013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-06 19:31:39
- Reporting Period:
- 2011-07-01
- Filing Date:
- 2011-07-06
- Accepted Time:
- 2011-07-06 19:31:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197355 | J Henry Fuchs | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Evp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-07-01 | 2,500 | $11.05 | 38,955 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-07-01 | 2,500 | $27.68 | 36,455 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2011-07-01 | 2,500 | $0.00 | 2,500 | $11.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
296,000 | 2009-09-02 | 2019-03-01 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 9, 2011.
- The range of sales prices received was $27.15 to $27.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- Original option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of each month thereafter.